AFFLUENT MEDICAL overview

EQS-News: Affluent Medical SA / Key word(s): Conference Affluent Medical Announces Participation in Upcoming Scientific Events 08.10.2024 / 17:45 CET/CEST The issuer is solely responsible for the content of this announcement. PRESS RELEASE Affluent Medical Announces Participation in Upcoming Scientific Events Aix-en-Provence, October 8, 2024 – 5:45 p.m. CEST – Affluent Medical (ISIN: FR0013333077 – Ticker: AFME – "Affluent"), a French clinical-stage medical technology company...

Affluent Medical Affluent Medical Announces Participation in Upcoming Scientific Events. 08-Oct-2024 / 17:45 CET/CEST Dissemination of a French Regulatory News, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. PRESS RELEASE Affluent Medical Announces Participation in Upcoming Scientific Events Aix-en-Provence, October 8, 2024 – 5:45 p.m. CEST – Affluent Medical (ISIN: FR0013333077 – Ticker: AFME – "Affluent"), a French clinical-stage...

EQS-News: Affluent Medical SA / Key word(s): Half Year Results Affluent Medical SA: H1 2024 RESULTS - Major advances in all three programs - Several strategic agreements signed with the world medtech leader in cardiology - Extension of financial runway 26.09.2024 / 17:45 CET/CEST The issuer is solely responsible for the content of this announcement. PRESS RELEASE H1 2024 RESULTS Major advances in all three programs Several strategic agreements signed with the world medtech leader in cardiology...

Affluent Medical Affluent Medical : H1 2024 results. 26-Sep-2024 / 17:45 CET/CEST Dissemination of a French Regulatory News, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. PRESS RELEASE H1 2024 RESULTS Major advances in all three programs Several strategic agreements signed with the world medtech leader in cardiology Extension of financial runway to July 2025 Several agreements signed in July 2024 with Edwards Lifesciences for an initial amount...

Affluent Medical Affluent Medical : Affluent Medical takes stock of its recent operational advances 12-Sep-2024 / 18:44 CET/CEST Dissemination of a French Regulatory News, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. PRESS RELEASE Affluent Medical takes stock of its recent operational advances Access the replay of the interview with Michel Therin, Chairman of the Board of Directors and Sébastien Ladet, CEO, on Boursorama Aix-en-Provence, 12...

EQS-News: Affluent Medical SA / Key word(s): Conference Affluent Medical to attend German Fall Conference in Frankfurt in September 2024 22.08.2024 / 07:30 CET/CEST The issuer is solely responsible for the content of this announcement. PRESS RELEASE Affluent Medical to attend German Fall Conference in Frankfurt in September 2024 Aix-en-Provence, August 22, 2024 – 7:30 am – Affluent Medical (ISIN: FR0013333077 – Ticker: AFME - “Affluent”), a French clinical-stage medical technology...

Affluent Medical Affluent Medical announces the availability of a prospectus for the admission to trading of 6,190,831 shares issued as part of a capital increase without preferential subscription rights. 15-Jul-2024 / 07:45 CET/CEST Dissemination of a French Regulatory News, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. PRESS RELEASE Affluent Medical announces the availability of a prospectus for the admission to trading of 6,190,831 shares...

EQS-News: Affluent Medical SA / Key word(s): Capital Increase Affluent Medical announces the availability of a prospectus for the admission to trading of 6,190,831 shares issued as part of a capital increase without preferential subscription rights in favour of 15.07.2024 / 07:45 CET/CEST The issuer is solely responsible for the content of this announcement. PRESS RELEASE Affluent Medical announces the availability of a prospectus for the admission to trading of 6,190,831 shares issued as part...